These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

574 related articles for article (PubMed ID: 35296338)

  • 1. Targeting the RNA m
    Li X; Ma S; Deng Y; Yi P; Yu J
    Mol Cancer; 2022 Mar; 21(1):76. PubMed ID: 35296338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Notch signaling pathway: a potential target for cancer immunotherapy.
    Li X; Yan X; Wang Y; Kaur B; Han H; Yu J
    J Hematol Oncol; 2023 May; 16(1):45. PubMed ID: 37131214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N
    Quan C; Belaydi O; Hu J; Li H; Yu A; Liu P; Yi Z; Qiu D; Ren W; Ma H; Gong G; Ou Z; Chen M; Sun Y; Chen J; Zu X
    Front Immunol; 2021; 12():697026. PubMed ID: 34526985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNA N
    Zhang Z; Zhang C; Luo Y; Zhang G; Wu P; Sun N; He J
    Clin Transl Med; 2021 Sep; 11(9):e525. PubMed ID: 34586737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic regulation in the tumor microenvironment: molecular mechanisms and therapeutic targets.
    Yang J; Xu J; Wang W; Zhang B; Yu X; Shi S
    Signal Transduct Target Ther; 2023 May; 8(1):210. PubMed ID: 37217462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Manipulating the tumour immune microenvironment by N6-methyladenosine RNA modification.
    Sun X; Wang H; Pu X; Wu Y; Yuan X; Wang X; Lu H
    Cancer Gene Ther; 2024 Sep; 31(9):1315-1322. PubMed ID: 38834772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N6-Methyladenosine RNA Modification in the Tumor Immune Microenvironment: Novel Implications for Immunotherapy.
    Guo L; Yang H; Zhou C; Shi Y; Huang L; Zhang J
    Front Immunol; 2021; 12():773570. PubMed ID: 34956201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multi-omics analysis of m
    Wu X; Bai Z
    Sci Rep; 2021 Oct; 11(1):20921. PubMed ID: 34686691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. m
    Zhang B; Wu Q; Li B; Wang D; Wang L; Zhou YL
    Mol Cancer; 2020 Mar; 19(1):53. PubMed ID: 32164750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation analysis of m6A-modified regulators with immune microenvironment infiltrating cells in lung adenocarcinoma.
    Ye W; Huang T
    PLoS One; 2022; 17(2):e0264384. PubMed ID: 35196365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. m
    Chong W; Shang L; Liu J; Fang Z; Du F; Wu H; Liu Y; Wang Z; Chen Y; Jia S; Chen L; Li L; Chen H
    Theranostics; 2021; 11(5):2201-2217. PubMed ID: 33500720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The potential role of m6A modifications on immune cells and immunotherapy.
    Gan L; Zhao Y; Fu Y; Chen Q
    Biomed Pharmacother; 2023 Apr; 160():114343. PubMed ID: 36758318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting RNA N6-methyladenosine to synergize with immune checkpoint therapy.
    Zhou X; Li C; Chen T; Li W; Wang X; Yang Q
    Mol Cancer; 2023 Feb; 22(1):36. PubMed ID: 36810108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. m
    Sun M; Xie M; Zhang T; Wang Y; Huang W; Xia L
    Front Immunol; 2021; 12():739768. PubMed ID: 34616403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. m6A regulator-mediated methylation modification patterns and tumor microenvironment infiltration characterization in hepatocellular carcinoma.
    Huang X; Qiu Z; Li L; Chen B; Huang P
    Aging (Albany NY); 2021 Aug; 13(16):20698-20715. PubMed ID: 34461607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent Advances of RNA m
    Ma S; Barr T; Yu J
    Cancer Treat Res; 2023; 190():49-94. PubMed ID: 38112999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting RNA N
    Li W; Hao Y; Zhang X; Xu S; Pang D
    Mol Cancer; 2022 Sep; 21(1):176. PubMed ID: 36071523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Non-N
    Xu J; Gao Z; Liu K; Fan Y; Zhang Z; Xue H; Guo X; Zhang P; Deng L; Wang S; Wang H; Wang Q; Zhao R; Li G
    Front Immunol; 2021; 12():809808. PubMed ID: 35154083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surmounting cancer drug resistance: New insights from the perspective of N
    Li B; Jiang J; Assaraf YG; Xiao H; Chen ZS; Huang C
    Drug Resist Updat; 2020 Dec; 53():100720. PubMed ID: 32892147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. m6A Regulators Mediated Methylation Modification Patterns and Tumor Microenvironment Infiltration Characterization In Nasopharyngeal Carcinoma.
    Liu Z; He J; Han J; Yang J; Liao W; Chen N
    Front Immunol; 2021; 12():762243. PubMed ID: 35069534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.